Company intelligence / Profile preview

Genzum Life Sciences

Los Angeles, California, United Statesgenzum.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Genzum Life Sciences specializes in developing high-barrier and complex generic pharmaceutical products. The company has completed at least one successful Phase 3 clinical trial demonstrating therapeutic equivalence of its topical naftifine hydrochloride cream to the branded product Naftin® in tinea pedis. Its business model focuses on precise reproduction of branded drugs as generics, with a strong emphasis on topical and sterile dosage forms.

Therapeutic areas: Infectious Diseases
Modalities: Topical creamSmall moleculeSterile formulationsComplex generics
Industry: Biotech

Partnerships

Commercial partners for co-development, manufacturing, and marketing of generic pharmaceuticals; specific names not disclosed but includes leading pharmaceutical companies

Beyond the preview

Go deeper on Genzum Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genzum Life Sciences.